Coronary Artery Clinical Trials

535 recruitingLast updated: May 11, 2026

There are 535 actively recruiting coronary artery clinical trials across 68 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include Seoul, South Korea, New York, New York, United States, Daegu, South Korea. Updated daily from ClinicalTrials.gov.


Coronary Artery Trials at a Glance

535 actively recruiting trials for coronary artery are listed on ClinicalTrialsFinder across 6 cities in 68 countries. The largest study group is Not Applicable with 207 trials, with the heaviest enrollment activity in Seoul, New York, and Daegu. Lead sponsors running coronary artery studies include Fundación EPIC, Seung-Jung Park, and China National Center for Cardiovascular Diseases.

Browse coronary artery trials by phase

Treatments under study

About Coronary Artery Clinical Trials

Looking for clinical trials for Coronary Artery? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronary Artery trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronary Artery clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 535 trials

Recruiting
Not Applicable

Coronary Artery Disease Assessment Strategies in TAVI Patients

Coronary Artery DiseaseTranscatheter Aortic Valve ReplacementHeart Disease Risk Factors
Insel Gruppe AG, University Hospital Bern546 enrolled1 locationNCT06559332
Recruiting
Phase 4

Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

Coronary Artery Disease
Massachusetts General Hospital200 enrolled1 locationNCT05850091
Recruiting

Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting

Coronary Artery Bypass
Peking University Third Hospital300 enrolled1 locationNCT06961136
Recruiting

Correlation of FFR CT With Invasive FFR in Multi-ethnic Cohort- a Retrospective Study

Coronary Artery Disease
Sandwell & West Birmingham Hospitals NHS Trust500 enrolled1 locationNCT06790836
Recruiting
Not Applicable

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Coronary Artery Disease
Teleflex150 enrolled19 locationsNCT06779630
Recruiting

SSVC-CI During CABG

Coronary Artery Bypass Grafting Surgery (CABG)
Milton S. Hershey Medical Center120 enrolled1 locationNCT06645327
Recruiting
Not Applicable

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

Coronary DiseaseCoronary Artery Disease
Fundación EPIC200 enrolled8 locationsNCT06736899
Recruiting
Phase 1Phase 2

A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients

Myocardial IschemiaCoronary Artery Disease
GE Healthcare54 enrolled5 locationsNCT04604782
Recruiting
Not Applicable

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

ANOCA - Angina With Non-obstructive Coronary ArteriesINOCA (Ischemia With Non Obstructive Coronary Artery Disease)
Baylor Research Institute50 enrolled1 locationNCT06896903
Recruiting
Phase 2

Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation

Coronary Artery Disease
Research Institute of Geroprotective Technologies180 enrolled1 locationNCT07397351
Recruiting
Phase 2Phase 3

Canagliflozin Targeting Vascular Inflammation

Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Recruiting

Coroflex® ISAR NEO PMCF Study

Coronary Artery Disease (CAD)Ischemic Heart Disease
Fundación EPIC3,000 enrolled22 locationsNCT05698732
Recruiting
Not Applicable

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Left Main Coronary Artery Stenosis
IGLESIAS Juan Fernando828 enrolled1 locationNCT05650411
Recruiting
Not Applicable

Hybrid Group Singing

ElderlyCoronary Artery Disease
Medical College of Wisconsin32 enrolled1 locationNCT07355192
Recruiting
Not Applicable

Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)Diffuse Coronary Artery Disease
University Hospital, Geneva150 enrolled1 locationNCT06710210
Recruiting

Scaffold in Emilia Romagna and in the MAGIC Network

Coronary Artery Disease
University Hospital of Ferrara1,111 enrolled17 locationsNCT03327961
Recruiting
Not Applicable

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Coronary Artery DiseaseHeart Failure, Systolic
Sunnybrook Health Sciences Centre754 enrolled43 locationsNCT05427370
Recruiting
Phase 2

Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

Coronary Artery DiseaseHeart Failure With Preserved Ejection Fraction (HFpEF)
King's College London350 enrolled1 locationNCT07560436
Recruiting

REGistry of Long-term AnTithrombotic TherApy-1

Peripheral Artery DiseaseCoronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation2,000 enrolled1 locationNCT04347200
Recruiting

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

Coronary Artery Disease (CAD)Optical Coherence Tomography (OCT)Coronary Computed Tomography Angiography (CCTA)
Insel Gruppe AG, University Hospital Bern816 enrolled1 locationNCT07565805